Extracellular AGR2 and ER-α can interact to induce the expression of IGF-1, thereby promoting the proliferation, migration and epithelial-mesenchymal transition process in breast cancer cells and enhancing drug resistance (48). The gene discussed is AGR2; the disease is breast carcinoma.